Q3/2020 12/31/2019 EPS 3.810 ZacksConsensus 3.540 ActVsEst 0.270 - Beat
McKesson Corporation (MCK)
Last mckesson corporation earnings: 2/4 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.mckesson.com
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
MCK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MCK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MCK alerts
High impacting McKesson Corporation news events
Weekly update
A roundup of the hottest topics
MCK
News
- McKesson Co. (NYSE: MCK) had its price target raised by analysts at Citigroup Inc. from $630.00 to $713.00. They now have a "buy" rating on the stock.MarketBeat
- All You Need to Know About McKesson (MCK) Rating Upgrade to Buy [Yahoo! Finance]Yahoo! Finance
- Virginia Cancer Specialists Initiates First Radiopharmaceutical Clinical Trial of Its Kind, Promising New Hope for Patients [Yahoo! Finance]Yahoo! Finance
- Are You a Value Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View Up [Yahoo! Finance]Yahoo! Finance
MCK
Earnings
- 11/6/24 - Beat
MCK
Sec Filings
- 11/7/24 - Form 10-Q
- 11/6/24 - Form 8-K
- 9/10/24 - Form 8-K
- MCK's page on the SEC website